Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL564P (RNA, 7SL, cytoplasmic 564, pseudogene) is a human **pseudogene** classified as a non-coding RNA locus located on chromosome 6[1][6][7]. Pseudogenes are nonfunctional genetic elements that have sequence similarity with functional genes but lack functionality due to disabling mutations or incomplete sequence[2]. RN7SL564P is specifically a pseudogene related to the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP), a ribonucleoprotein required for protein targeting to the endoplasmic reticulum in cells[3][5]. However, as a pseudogene, RN7SL564P **does not produce a functional RNA or protein**[2][1]. There is no therapeutic relevance, no interaction with drugs, no established biological function, and no known roles in disease, biomarkers, or safety concerns. Its existence may complicate some molecular biology studies due to sequence homology with functional 7SL RNA genes, potentially leading to PCR or annotation artifacts[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 564, pseudogene (RN7SL564P).